Free Trial

Keurig Dr Pepper Inc. (NASDAQ:KDP) Shares Purchased by Sumitomo Mitsui DS Asset Management Company Ltd

Keurig Dr Pepper logo with Consumer Staples background

Sumitomo Mitsui DS Asset Management Company Ltd boosted its stake in shares of Keurig Dr Pepper Inc. (NASDAQ:KDP - Free Report) by 12.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 146,722 shares of the company's stock after buying an additional 16,439 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd's holdings in Keurig Dr Pepper were worth $4,713,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in KDP. CX Institutional increased its holdings in shares of Keurig Dr Pepper by 3.6% in the 3rd quarter. CX Institutional now owns 8,129 shares of the company's stock worth $305,000 after purchasing an additional 283 shares in the last quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors increased its holdings in shares of Keurig Dr Pepper by 3.6% in the 3rd quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors now owns 8,535 shares of the company's stock worth $320,000 after purchasing an additional 300 shares in the last quarter. Perigon Wealth Management LLC increased its holdings in shares of Keurig Dr Pepper by 1.2% in the 4th quarter. Perigon Wealth Management LLC now owns 28,545 shares of the company's stock worth $893,000 after purchasing an additional 342 shares in the last quarter. Custom Index Systems LLC increased its holdings in shares of Keurig Dr Pepper by 5.3% in the 4th quarter. Custom Index Systems LLC now owns 7,109 shares of the company's stock worth $228,000 after purchasing an additional 357 shares in the last quarter. Finally, First Hawaiian Bank increased its holdings in shares of Keurig Dr Pepper by 5.2% in the 4th quarter. First Hawaiian Bank now owns 7,789 shares of the company's stock worth $250,000 after purchasing an additional 384 shares in the last quarter. Institutional investors own 93.99% of the company's stock.

Insiders Place Their Bets

In related news, major shareholder Bevco B.V. Jab bought 3,619,600 shares of the stock in a transaction on Wednesday, January 29th. The stock was bought at an average price of $33.34 per share, for a total transaction of $120,677,464.00. Following the completion of the acquisition, the insider now directly owns 218,063,479 shares in the company, valued at approximately $7,270,236,389.86. This represents a 1.69 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.00% of the stock is owned by company insiders.

Keurig Dr Pepper Trading Up 0.3 %

Shares of NASDAQ KDP traded up $0.11 during trading hours on Wednesday, reaching $31.67. The stock had a trading volume of 6,950,809 shares, compared to its average volume of 8,185,411. The company has a current ratio of 0.53, a quick ratio of 0.36 and a debt-to-equity ratio of 0.50. The firm has a market cap of $42.96 billion, a price-to-earnings ratio of 19.19, a P/E/G ratio of 2.16 and a beta of 0.61. The business's fifty day moving average price is $31.94 and its two-hundred day moving average price is $34.06. Keurig Dr Pepper Inc. has a 52-week low of $28.61 and a 52-week high of $38.28.

Keurig Dr Pepper Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be issued a $0.23 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.92 dividend on an annualized basis and a dividend yield of 2.90%. Keurig Dr Pepper's payout ratio is 55.76%.

Wall Street Analyst Weigh In

Several brokerages recently commented on KDP. Citigroup cut their price objective on Keurig Dr Pepper from $43.00 to $40.00 and set a "buy" rating for the company in a report on Friday, October 25th. UBS Group lowered their target price on Keurig Dr Pepper from $42.00 to $37.00 and set a "buy" rating on the stock in a research report on Thursday, January 16th. Jefferies Financial Group lowered their price objective on Keurig Dr Pepper from $42.00 to $41.00 and set a "buy" rating on the stock in a research report on Friday, October 25th. Wells Fargo & Company lowered their price objective on Keurig Dr Pepper from $42.00 to $40.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 7th. Finally, Deutsche Bank Aktiengesellschaft raised Keurig Dr Pepper from a "hold" rating to a "buy" rating and lifted their target price for the stock from $37.00 to $39.00 in a report on Thursday, December 12th. Six equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $37.50.

Read Our Latest Analysis on KDP

Keurig Dr Pepper Profile

(Free Report)

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.

Further Reading

Institutional Ownership by Quarter for Keurig Dr Pepper (NASDAQ:KDP)

Should You Invest $1,000 in Keurig Dr Pepper Right Now?

Before you consider Keurig Dr Pepper, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.

While Keurig Dr Pepper currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines